StonvexLoading…
StonvexStonvexStonvexCore line items from TYL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.33B | $2.14B | $1.95B | $1.85B |
Operating Income | $357.68M | $299.53M | $218.54M | $214.25M |
Net Income | $315.60M | $263.03M | $165.92M | $164.24M |
EPS (Diluted) | $7.20 | $6.05 | $3.88 | $3.87 |
Total Assets | $5.64B | $5.18B | $4.68B | $4.69B |
Total Liabilities | $1.94B | $1.79B | $1.74B | $2.06B |
Cash & Equivalents | $1.02B | $744.72M | $165.49M | $173.86M |
Free Cash Flow OCF − CapEx | $637.53M | $604.10M | $359.92M | $358.93M |
Shares Outstanding | 43.81M | 43.50M | 42.77M | 42.40M |